Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients

Kaohsiung Journal of Medical Sciences

Volumn 15, Issue 2, 1999, Pages 62-68

  Wu, S G ^a   Lin, S L ^a   Wu, C M ^a   Jeng, F R ^a   Su, C Z ^a  

^a Division of Nephrology   (Taiwan)

Author keywords

Hemodialysis; Ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; NIFEDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; UREMIA;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RENAL DIALYSIS; UREMIA;

EID: 0032993830     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)